134 related articles for article (PubMed ID: 38226867)
1. Cu(II) complexes with a salicylaldehyde derivative and α-diimines as co-ligands: synthesis, characterization, biological activity. Experimental and theoretical approach.
Selaković S; Rodić MV; Novaković I; Matić IZ; Stanojković T; Pirković A; Živković L; Spremo-Potparević B; Milčić M; Medaković V; Dimiza F; Psomas G; Anđelković K; Šumar-Ristović M
Dalton Trans; 2024 Feb; 53(6):2770-2788. PubMed ID: 38226867
[TBL] [Abstract][Full Text] [Related]
2. Copper(II) complexes with 4-(diethylamino)salicylaldehyde and α-diimines: Anticancer, antioxidant, antigenotoxic effects and interaction with DNA and albumins.
Vitomirov T; Dimiza F; Matić IZ; Stanojković T; Pirković A; Živković L; Spremo-Potparević B; Novaković I; Anđelković K; Milčić M; Psomas G; Ristović MŠ
J Inorg Biochem; 2022 Oct; 235():111942. PubMed ID: 35917705
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure information, DNA/BSA binding affinity and in vitro cytotoxic studies of mixed ligand copper(II) complexes containing a phenylalanine derivative and diimine co-ligands.
Annaraj B; Balakrishnan C; Neelakantan MA
J Photochem Photobiol B; 2016 Jul; 160():278-91. PubMed ID: 27155593
[TBL] [Abstract][Full Text] [Related]
4. Zinc(II) complexes of 3,5-dibromo-salicylaldehyde and α-diimines: Synthesis, characterization and in vitro and in silico biological profile.
Zianna A; Geromichalou E; Geromichalos G; Fiotaki AM; Hatzidimitriou AG; Kalogiannis S; Psomas G
J Inorg Biochem; 2022 Jan; 226():111659. PubMed ID: 34801971
[TBL] [Abstract][Full Text] [Related]
5. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.
Anupama B; Aruna A; Manga V; Sivan S; Sagar MV; Chandrashekar R
J Fluoresc; 2017 May; 27(3):953-965. PubMed ID: 28097460
[TBL] [Abstract][Full Text] [Related]
7. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
[TBL] [Abstract][Full Text] [Related]
8. Copper(II) complexes with antimicrobial drug flumequine: structure and biological evaluation.
Chalkidou E; Perdih F; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2012 Aug; 113():55-65. PubMed ID: 22694822
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of mixed chelate copper(II) complexes, with substituted diimine and tridentate Schiff bases (NNO) and their hydrogenated derivatives as secondary ligands: Casiopeína's fourth generation.
Novoa-Ramírez CS; Silva-Becerril A; González-Ballesteros MM; Gomez-Vidal V; Flores-Álamo M; Ortiz-Frade L; Gracia-Mora J; Ruiz-Azuara L
J Inorg Biochem; 2023 May; 242():112097. PubMed ID: 36812707
[TBL] [Abstract][Full Text] [Related]
10. Mixed ligand copper(II)-diimine complexes of 2-formylpyridine-
Kartikeyan R; Murugan D; Ajaykamal T; Varadhan M; Rangasamy L; Velusamy M; Palaniandavar M; Rajendiran V
Dalton Trans; 2023 Jul; 52(26):9148-9169. PubMed ID: 37341481
[TBL] [Abstract][Full Text] [Related]
11. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
[TBL] [Abstract][Full Text] [Related]
12. Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity.
Mutlu Gençkal H; Erkisa M; Alper P; Sahin S; Ulukaya E; Ari F
J Biol Inorg Chem; 2020 Feb; 25(1):161-177. PubMed ID: 31832781
[TBL] [Abstract][Full Text] [Related]
13. Structure and in vitro and in silico biological activity of zinc(II) complexes with 3,5-dichloro-salicylaldehyde.
Zianna A; Geromichalos G; Psoma E; Kalogiannis S; Hatzidimitriou AG; Psomas G
J Inorg Biochem; 2022 Apr; 229():111727. PubMed ID: 35093777
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis,
Mudavath R; Vuradi RK; Bathini U; Narsimha N; Kunche S; Sunitha S; Ch SD
Nucleosides Nucleotides Nucleic Acids; 2019; 38(11):874-900. PubMed ID: 31148514
[TBL] [Abstract][Full Text] [Related]
15. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
16. Bis(μ-chloro) bridged 1D Cu
Thirunavukkarasu T; Sparkes HA; Balachandran C; Awale S; Natarajan K; Gnanasoundari VG
J Photochem Photobiol B; 2018 Apr; 181():59-69. PubMed ID: 29510357
[TBL] [Abstract][Full Text] [Related]
17. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
18. Zinc(II) complexes of 3-bromo-5-chloro-salicylaldehyde: characterization and biological activity.
Zianna A; Vradi E; Hatzidimitriou AG; Kalogiannis S; Psomas G
Dalton Trans; 2022 Nov; 51(46):17629-17641. PubMed ID: 36342040
[TBL] [Abstract][Full Text] [Related]
19. Bio-active mixed ligand Cu(II) and Zn(II) complexes of pyrimidine derivative Schiff base: DFT calculation, antimicrobial, antioxidant, DNA binding, anticancer and molecular docking studies.
Revathi N; Sankarganesh M; Dhaveethu Raja J; Vinoth Kumar GG; Sakthivel A; Rajasekaran R
J Biomol Struct Dyn; 2021 May; 39(8):3012-3024. PubMed ID: 32329409
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1
Cai DH; Chen BH; Liu QY; Le XY; He L
Dalton Trans; 2022 Nov; 51(43):16574-16586. PubMed ID: 36263706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
